HomeCompareCTTMF vs MRK

CTTMF vs MRK: Dividend Comparison 2026

CTTMF yields 1025.64% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTTMF wins by $23506543.47M in total portfolio value
10 years
CTTMF
CTTMF
● Live price
1025.64%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23506543.53M
Annual income
$19,723,609,349,823.79
Full CTTMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CTTMF vs MRK

📍 CTTMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTTMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTTMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTTMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTTMF
Annual income on $10K today (after 15% tax)
$87,179.49/yr
After 10yr DRIP, annual income (after tax)
$16,765,067,947,350.22/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, CTTMF beats the other by $16,765,067,938,753.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTTMF + MRK for your $10,000?

CTTMF: 50%MRK: 50%
100% MRK50/50100% CTTMF
Portfolio after 10yr
$11753271.79M
Annual income
$9,861,804,679,968.79/yr
Blended yield
83.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CTTMF
No analyst data
Altman Z
1.0
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTTMF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTTMFMRK
Forward yield1025.64%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$23506543.53M$57.7K
Annual income after 10y$19,723,609,349,823.79$10,113.78
Total dividends collected$23218513.75M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CTTMF vs MRK ($10,000, DRIP)

YearCTTMF PortfolioCTTMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$113,264$102,564.10$11,213$373.04+$102.1KCTTMF
2$1,206,878$1,085,685.14$12,667$512.06+$1.19MCTTMF
3$12,102,987$10,811,628.23$14,439$708.14+$12.09MCTTMF
4$114,279,868$101,329,670.98$16,640$988.16+$114.26MCTTMF
5$1,016,469,856$894,190,397.43$19,432$1,394.07+$1016.45MCTTMF
6$8,520,740,273$7,433,117,527.67$23,057$1,992.90+$8520.72MCTTMF
7$67,350,310,269$58,233,118,176.66$27,889$2,894.79+$67350.28MCTTMF
8$502,243,173,894$430,178,341,906.41$34,518$4,286.29+$502243.14MCTTMF
9$3,535,452,502,858$2,998,052,306,790.74$43,912$6,494.35+$3535452.46MCTTMF
10$23,506,543,527,881$19,723,609,349,823.79$57,714$10,113.78+$23506543.47MCTTMF

CTTMF vs MRK: Complete Analysis 2026

CTTMFStock

Catena Media plc, together with its subsidiaries, provides lead generation and related services for operators of online casino, sports betting, and financial trading platforms. It operates through three segments: Casino, Sports, and Financial Trading. The Casino segment provides content, insights, and offers that connects people interested in slots, poker, blackjack, and other casino games with selected platform operators. The Sports segment publishes targeted content, as well as background on sports teams, individuals, and fixtures that informs sports, fantasy sports, and esports betting fans and helps to choose the right offers from online operators. The Financial Trading segment provides content on financial investing in markets, such as equities, foreign exchange, and cryptocurrencies. It also owns and develops websites and media platforms, which attract visitors through traffic and paid marketing. The company operates in Africa, Asia, the Middle East, Europe, Latin America, North America, and Oceania. Catena Media plc was founded in 2008 and is headquartered in Gzira, Malta.

Full CTTMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CTTMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTTMF vs SCHDCTTMF vs JEPICTTMF vs OCTTMF vs KOCTTMF vs MAINCTTMF vs JNJCTTMF vs ABBVCTTMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.